尼泊金甲酯检测

检测信息

尼泊金甲酯是一种对羟基苯甲酸甲酯类防腐剂，广泛应用于化妆品、药品、食品及日化产品中，主要通过抑制霉菌和酵母菌生长来延长产品保质期。

检测目的在于确认尼泊金甲酯的纯度、含量及杂质水平，确保其在各类产品中的使用符合国家限量标准，主要采用高效液相色谱法和气相色谱法进行定量分析。

检测流程包括样品前处理、标准品对照、仪器分析及数据计算，核心参数涵盖含量测定、有关物质检查和残留溶剂分析。

检测范围

• 化妆品级尼泊金甲酯
• 药品级尼泊金甲酯
• 食品级尼泊金甲酯
• 工业级尼泊金甲酯
• 尼泊金甲酯钠
• 尼泊金甲酯原料药
• 尼泊金甲酯标准品
• 高纯度尼泊金甲酯
• 尼泊金甲酯粉末
• 尼泊金甲酯溶液
• 复合尼泊金甲酯
• 水溶性尼泊金甲酯
• 油溶性尼泊金甲酯
• 尼泊金甲酯钠盐
• 含尼泊金甲酯乳液
• 含尼泊金甲酯膏霜
• 含尼泊金甲酯香波
• 含尼泊金甲酯洗剂
• 含尼泊金甲酯片剂
• 含尼泊金甲酯胶囊
• 含尼泊金甲酯糖浆
• 含尼泊金甲酯注射液
• 尼泊金甲酯复配防腐剂
• 尼泊金甲酯混合酯

检测标准（部分）

• GB/T 39606-2020 纺织品 尼泊金酯类抗菌剂的测定
• USP f100446 Methylparaben
• SN/T 3226-2012 纺织品与皮革制品中尼泊金酯类防腐剂的测定
• USP f100520 Propylparaben
• T/SQIA 002-2022 蔬菜水果中甲氰菊酯、氯氰菊酯及氯氟氰菊酯的快速检测 胶体金免疫层析法
• 32012R1197 Commission Implementing Regulation (EU) No 1197/2012 of 13 December 2012 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, alpha-cypermethrin, Ampelomyces quisqualis Strain: AQ 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum Strain: J1446, imazosulfuron, laminarin, mepanipyrim, methoxyfenozide, milbemectin, p
• 32009R1050 Commission Regulation (EC) No 1050/2009 of 28 October 2009 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron, fluopicolide, indoxacarb, ioxynil, mepanipyrim, prothioconazole, pyridalyl, thiacloprid and trifloxystrobin in or on certain product
• 32019R0552 Commission Regulation (EU) 2019/552 of 4 April 2019 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, bicyclopyrone, chlormequat, cyprodinil, difenoconazole, fenpropimorph, fenpyroximate, fluopyram, fosetyl, isoprothiolane, isopyrazam, oxamyl, prothioconazole, spinetoram, trifloxystrobin and triflumezopyrim in or on certain products (Text wi
• 32018R0687 Commission Regulation (EU) 2018/687 of 4 May 2018 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acibenzolar-S-methyl, benzovindiflupyr, bifenthrin, bixafen, chlorantraniliprole, deltamethrin, flonicamid, fluazifop-P, isofetamid, metrafenone, pendimethalin and teflubenzuron in or on certain products (Text with EEA relevance)
• 32016R0001 Commission Regulation (EU) 2016/1 of 3 December 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, boscalid, cyazofamid, cyromazine, dazomet, dithiocarbamates, fluazifop-P, mepanipyrim, metrafenone, picloram, propamocarb, pyridaben, pyriofenone, sulfoxaflor, tebuconazole, tebufenpyrad and thiram in or on certain products (Text with EEA rel
• 32015R0845R(01) Corrigendum to Commission Regulation (EU) 2015/845 of 27 May 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, chlorantraniliprole, cyantraniliprole, dicamba, difenoconazole, fenpyroximate, fludioxonil, glufosinate-ammonium, imazapic, imazapyr, indoxacarb, isoxaflutole, mandipropamid, penthiopyrad, propiconazole, pyrimethanil, spirotetr
• 32016R0567 Commission Regulation (EU) 2016/567 of 6 April 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chlorantraniliprole, cyflumetofen, cyprodinil, dimethomorph, dithiocarbamates, fenamidone, fluopyram, flutolanil, imazamox, metrafenone, myclobutanil, propiconazole, sedaxane and spirodiclofen in or on certain products (Text with EEA relevance)
• 32014R0491 Commission Regulation (EU) No 491/2014 of 5 May 2014 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, azoxystrobin, cycloxydim, cyfluthrin, dinotefuran, fenbuconazole, fenvalerate, fludioxonil, fluopyram, flutriafol, fluxapyroxad, glufosinate-ammonium, imidacloprid, indoxacarb, MCPA, methoxyfenozide, penthiopyrad, spinetoram and trifloxystr
• 32011R0813 Commission Regulation (EU) No 813/2011 of 11 August 2011 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, emamectin benzoate, ethametsulfuron-methyl, flubendiamide, fludioxonil, kresoxim-methyl, methoxyfenozide, novaluron, thiacloprid and trifloxystrobin in or on certain products Text with EEA relevance
• 32009R1050R(01) Corrigendum to Commission Regulation (EC) No 1050/2009 of 28 October 2009 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron, fluopicolide, indoxacarb, ioxynil, mepanipyrim, prothioconazole, pyridalyl, thiacloprid and trifloxystrobin in or on
• 32002D0658 2002/658/EC: Commission Decision of 14 August 2002 allowing Member States to extend provisional authorisations granted for the new active substances benzoic acid, carvone, mepanipyrim, oxadiargyl and trifloxystrobin (Text with EEA relevance) (notified under document number C(2002) 3048)
• 32010R0893 Commission Regulation (EU) No 893/2010 of 8 October 2010 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, bentazone, carbendazim, cyfluthrin, fenamidone, fenazaquin, flonicamid, flutriafol, imidacloprid, ioxynil, metconazole, prothioconazole, tebufenozide and thiophanate-methyl in or on certain products Text with EEA relevance
• 32012R0899R(01) Berichtigung der Verordnung (EU) Nr. 899/2012 der Kommission vom 21. September 2012 zur?nderung der Anh?nge IIund III der Verordnung (EG) Nr. 396/2005 des Europ?ischen Parlaments unddes Rates hinsichtlich der R?ckstandsh?chstgehalte f?r Acephat,Alachlor, Anilazin, Azocyclotin, Benfuracarb, Butylat, Captafol,Carbaryl, Carbofuran, Carbosulfan, Chlorfenapyr, Chlorthal-dimethyl,Chlorthiamid, Cyhexatin, Diazinon, Dichlobenil, Dicofol, Dimethipin,Dini
• 32002D0133 2002/133/EC: Commission Decision of 18 February 2002 making it possible for Member States to extend provisional authorisations granted for the new active substances carfentrazone-ethyl, cinidon-ethyl, cyhalofop-butyl, ethoxysulfuron, famoxadone, flazasulfuron, flufenacet, flumioxazine, flurtamone, fosthiazate, isoxaflutole, metalaxyl-M, prosulfuron, Pseudomonas chlororaphis, quinoxyfen, Spodoptera exigua nuclear polyhedrosis virus and sulfosulfur

尼泊金甲酯检测项目

• 含量测定：通过色谱法确定尼泊金甲酯中有效成分的百分比含量，判定是否符合产品规格要求
• 纯度分析：检测样品中主成分与杂质的比例，评估原料纯度等级
• 水分测定：采用卡尔费休法测定样品中水分含量，防止水分超标影响产品稳定性
• 灼烧残渣：检测样品经高温灼烧后的残留物质量，反映样品中无机杂质含量
• 重金属限量：采用原子吸收光谱法测定铅、砷、汞等重金属含量，确保使用安全性
• pH值测定：测量尼泊金甲酯溶液的酸碱度，控制产品在适用范围内
• 熔点测定：通过毛细管法测定样品熔化温度，辅助鉴别产品纯度
• 干燥失重：检测样品在规定温度下干燥后的减失重量，评估挥发性物质含量
• 有关物质检查：采用HPLC法检测合成过程中残留的副产物和降解产物
• 残留溶剂测定：通过气相色谱法检测生产过程中使用的有机溶剂残留量
• 硫酸盐灰分：测定样品中硫酸盐不溶性灰分，评估无机杂质水平
• 氯化物限量：检测样品中氯化物杂质含量，控制产品质量
• 砷盐限量：采用原子荧光法测定砷含量，确保符合药典限量要求
• 铅含量测定：通过ICP-MS法精确测定铅元素含量，评估安全性
• 微生物限度：检测样品中细菌总数、霉菌和酵母菌数量，确保卫生指标合格
• 鉴别试验：通过红外光谱法和紫外光谱法确认样品与尼泊金甲酯标准品一致性
• 溶液澄清度：检测样品溶解后的溶液澄清程度，评估杂质水平
• 溶液颜色：通过比色法测定样品溶液的色度，控制外观质量
• 酸度测定：检测样品中游离酸含量，评估化学稳定性
• 游离对羟基苯甲酸：采用色谱法测定未酯化的对羟基苯甲酸含量，控制反应完全度
• 粒度分布：通过激光粒度仪测定粉末样品的粒径分布，评估使用性能

常见问题

尼泊金甲酯检测需要多长时间？

通常7-15个工作日，具体时长根据检测项目数量和样品类型确定，加急服务可缩短至3-5个工作日。

尼泊金甲酯检测费用大概多少？

根据检测项目数量确定，单项检测费用通常在几百元至数千元不等，具体费用需根据客户实际检测需求制定方案后报价。

尼泊金甲酯检测报告有什么用途？

可用于质量评估、项目验收、产品上市备案及研发改进，北京中科光析科学技术研究所检测中心旗下实验室拥有CMA、CNAS、ISO等检验检测资质。

尼泊金甲酯在不同产品中的限量标准是多少？

化妆品中很大允许浓度通常为0.4%（单一酯）或0.8%（混合酯），食品中根据GB 2760规定限量使用，药品中需符合药典相关要求，具体限量需参照对应产品标准。

总结

尼泊金甲酯检测是对该防腐剂原料及含该成分产品的含量、纯度、杂质及安全性指标的测定分析。北京中科光析科学技术研究所检测中心旗下实验室拥有CMA、CNAS、ISO等检验检测资质。检测周期通常为7-15个工作日，报告可用于质量评估、项目验收及产品备案等用途。

相关检测

• 香茅油检测
• 珠光片检测
• 冰片检测